114 related articles for article (PubMed ID: 1926582)
1. [Plasminogen activation by a tissue activator and effector properties of fibrinogen-N-terminal disulfide (N-DSK) fibrin complex].
Makogonenko EM; Druzhina NN; Lugovskoĭ EV; Kolesnik LA; Kudinov SA
Ukr Biokhim Zh (1978); 1991; 63(3):17-23. PubMed ID: 1926582
[TBL] [Abstract][Full Text] [Related]
2. Studies of the t-PA-catalyzed Glu-plasminogen activation on different models of polymeric fibrin.
Druzhyna NN; Makogonenko EM; Yakovlev SA
Thromb Res; 1997 Jul; 87(1):131-9. PubMed ID: 9253808
[TBL] [Abstract][Full Text] [Related]
3. Comparison of kinetic parameters of the activation of Glu-plasminogen by tissue plasminogen activator obtained from various sources.
Takada A; Sugawara Y; Takada Y
Haemostasis; 1988; 18(2):117-25. PubMed ID: 3137140
[TBL] [Abstract][Full Text] [Related]
4. Fibrin-mediated plasminogen activation.
Nieuwenhuizen W
Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
7. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
8. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
9. A region of tissue plasminogen activator that affects plasminogen activation differentially with various fibrin(ogen)-related stimulators.
Eastman D; Wurm FM; van Reis R; Higgins DL
Biochemistry; 1992 Jan; 31(2):419-22. PubMed ID: 1731899
[TBL] [Abstract][Full Text] [Related]
10. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
Pozdniakova TM; Rybachuk VN; Vovk EV
Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.
Tran-Thang C; Kruithof EK; Bachmann F
J Clin Invest; 1984 Dec; 74(6):2009-16. PubMed ID: 6210307
[TBL] [Abstract][Full Text] [Related]
12. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
[TBL] [Abstract][Full Text] [Related]
13. [The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].
Taran LD; Makogonenko EM
Ukr Biokhim Zh (1978); 1989; 61(4):31-6. PubMed ID: 2511651
[TBL] [Abstract][Full Text] [Related]
14. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis.
Jones AJ; Meunier AM
Thromb Haemost; 1990 Nov; 64(3):455-63. PubMed ID: 2128976
[TBL] [Abstract][Full Text] [Related]
15. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
Savchuk AN
Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
Liu JN; Gurewich V
J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
Stewart RJ; Fredenburgh JC; Rischke JA; Bajzar L; Weitz JI
J Biol Chem; 2000 Nov; 275(47):36612-20. PubMed ID: 10970891
[TBL] [Abstract][Full Text] [Related]
18. [Binding of alpha-2-antiplasmin with fibrinogen/fibrin and their fragments independent of factor XIII].
Zadorozhna MB; Hrynenko TV; Iusova OI; Volkov HL
Ukr Biokhim Zh (1999); 2004; 76(5):71-7. PubMed ID: 16100900
[TBL] [Abstract][Full Text] [Related]
19. Differences between neonates and adults in tissue-type-plasminogen activator (t-PA)-catalyzed plasminogen activation with various effectors and in carbohydrate sequences of fibrinogen chains.
Ries M; Easton RL; Longstaff C; Zenker M; Corran PH; Morris HR; Dell A; Gaffney PJ
Thromb Res; 2001 Aug; 103(3):173-84. PubMed ID: 11672579
[TBL] [Abstract][Full Text] [Related]
20. Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.
de Serrano VS; Urano T; Gaffney PJ; Castellino FJ
J Protein Chem; 1989 Feb; 8(1):61-77. PubMed ID: 2527513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
